Abstract
The presence of acanthocytosis in peripheral blood smears remains the hallmark of the clinical diagnosis of most neuroacanthocytosis syndromes, such as chorea-acanthocytosis (ChAc) and McLeod syndrome. Genetic analyses and/or specific laboratory tests are available only for a minority of these disorders. Testing for acanthocytosis is hampered by the lack of data on normal amounts of acanthocytes assessed by a standardized method. We report a prospective reader-blinded study designed to establish control values for abnormally shaped erythrocytes in healthy volunteers and patients with movement disorders (MDs) using light microscopic assessment of erythrocyte morphology in standard EDTA and isotonically diluted blood samples. We investigated a total of 100 patients fulfilling clinical criteria of specific MDs, 31 patients with MDs not matching any clinical criteria, and 37 healthy controls. In patients with diagnosed MDs and healthy controls, acanthocytes in dry blood smears were significantly more frequent following isotonic dilution compared with standard EDTA blood. In unfixed wet blood preparations of both EDTA blood and isotonically diluted blood, acanthocyte levels were significantly higher than in standard dry blood smear preparations. There were no statistical differences of acanthocyte levels in all test conditions between diagnosed MDs and healthy volunteers. There was no significant correlation of acanthocyte levels in all blood samples and preparations with age, sex or diagnosis. Thus, normal values were defined as the 99th percentile of combined results of the two groups of volunteers. Diluted blood combined with wet blood preparation showed high specificity (0.98) and the highest sensitivity of all test procedures (all genetically confirmed ChAc patients were detected). The reported method is cheap, readily available, and provides high specificity and sensitivity in respect to clinically relevant acanthocytosis. The use of isotonically diluted blood samples combined with unfixed wet blood preparation with a normal range of <6.3% of total erythrocytes is recommended to search for significant acanthocytosis in movement disorders.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brin M (1993) Acanthocytosis. In: Goetz C, Tanner C, Aminoff M (eds) Handbook of Clinical Neurology. Elsevier, Amsterdam, pp 271–299
Danek A, Rubio JP, Rampoldi L, Ho M, Dobson-Stone C, Tison F, Symmans WA, Oechsner M, Kalckreuth W, Watt JM, Corbett AJ, Hamdalla HH, Marshall AG, Sutton I, Dotti MT, Malandrini A, Walker RH, Daniels G, Monaco AP (2001) McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol 50:755–764
Dobson-Stone C, Danek A, Rampoldi L, Hardie RJ, Chalmers RM, Wood NW, Bohlega S, Dotti MT, Federico A, Shizuka M, Tanaka M, Watanabe M, Ikeda Y, Brin M, Goldfarb LG, Karp BI, Mohiddin S, Fananapazir L, Storch A, Fryer AE, Maddison P, Sibon I, Trevisol-Bittencourt PC, Singer C, Caballero IR, Aasly JO, Schmierer K, Dengler R, Hiersemenzel LP, Zeviani M, Meiner V, Lossos A, Johnson S, Mercado FC, Sorrentino G, Dupre N, Rouleau GA, Volkmann J, Arpa J, Lees A, Geraud G, Chouinard S, Nemeth A, Monaco AP (2002) Mutational spectrum of the CHAC gene in patients with choreaacanthocytosis. Eur J Hum Genet 10:773–781
Feinberg TE, Cianci CD, Morrow JS, Pehta JC, Redman CM, Huima T, Koroshetz WJ (1991) Diagnostic tests for choreoacanthocytosis. Neurology 41:1000–1006
Hardie RJ, Pullon HW, Harding AE, Owen JS, Pires M, Daniels GL, Imai Y, Misra VP, King RH, Jacobs JM, et al. (1991) Neuroacanthocytosis. A clinical, haematological and pathological study of 19 cases. Brain 114:13–49
Lessin LS, Klug PP, Jensen WN (1976) Clinical implications of red cell shape. Adv Intern Med 21:451–500
Malandrini A, Fabrizi GM, Palmeri S, Ciacci G, Salvadori C, Berti G, Bucalossi A, Federico A, Guazzi GC (1993) Choreo-acanthocytosis like phenotype without acanthocytes: clinicopathological case report. A contribution to the knowledge of the functional pathology of the caudate nucleus. Acta Neuropathol (Berl) 86:651–658
Rampoldi L, Dobson-Stone C, Rubio JP, Danek A, Chalmers RM, Wood NW, Verellen C, Ferrer X, Malandrini A, Fabrizi GM, Brown R, Vance J, Pericak-Vance M, Rudolf G, Carre S, Alonso E, Manfredi M, Nemeth AH, Monaco AP (2001) A conserved sorting-associated protein is mutant in chorea-acanthocytosis. Nat Genet 28:119–120
Redman CM, Huima T, Robbins E, Lee S, Marsh WL (1989) Effect of phosphatidylserine on the shape of McLeod red cell acanthocytes. Blood 74:1826–1835
Shibasaki H, Sakai T, Nishimura H, Sato Y, Goto I, Kuroiwa Y (1982) Involuntary movements in chorea-acanthocytosis: a comparison with Huntington’s chorea. Ann Neurol 12:311–314
Stevenson VL, Hardie RJ (2001) Acanthocytosis and neurological disorders. J Neurol 248:87–94
Ueno S, Maruki Y, Nakamura M, Tomemori Y, Kamae K, Tanabe H, Yamashita Y, Matsuda S, Kaneko S, Sano A (2001) The gene encoding a newly discovered protein, chorein, is mutated in chorea-acanthocytosis. Nat Genet 28:121–122
Vance JM, Pericak-Vance MA, Bowman MH, Payne CS, Fredane L, Siddique T, Roses AD, Massey EW (1987) Chorea-acanthocytosis: a report of three new families and implications for genetic counselling. Am J Med Genet 28:403–410
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Storch, A., Kornhass, M. & Schwarz, J. Testing for acanthocytosis. J Neurol 252, 84–90 (2005). https://doi.org/10.1007/s00415-005-0616-3
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00415-005-0616-3